
People will still be subject to criminal penalties for mere possession, regardless of their legal status in a state-level medical program,” cannabis advocate Justin Strekal told POLITICO on Wednesday. “Rescheduling cannabis from 1 to 3 does not end criminalization, it just rebrands it. Legalization advocates on Wednesday reiterated that rescheduling would not solve many of the problem they’ve been asking the Biden administration to correct. Biden’s executive action - which also included federal pardons for low-level marijuana convictions - was seen by many as a political move taken ahead of the midterm elections to incentivize turnout among younger and more progressive voters.Īt the time, advocates and some lawmakers urged Biden to take clear steps to remove cannabis completely from the CSA - versus rescheduling it. The HHS recommendation is the result of a nearly yearlong federal review of all available marijuana research. Schedule III drugs are categorized as having “moderate to low potential for physical and psychological dependence.” The category includes ketamine and testosterone. Heroin and LSD are also Schedule I drugs. “We’re just not going to comment on that.”Ĭannabis is currently a Schedule I substance on the CSA, which means it is deemed to have a high likelihood of abuse and no medical uses. “The administration process is an independent process led by HHS, led by the Department of Justice, and guided by evidence,” White House Press Secretary Karine Jean-Pierre told reporters. The White House on Wednesday refused to comment on the review process. The DEA is not required to follow HHS’s recommendation. The HHS letter is part of the official review process initiated by President Joe Biden last October: The FDA conducts the review, which is then sent to the National Institute on Drug Abuse and HHS, after which HHS transmits a letter of recommendation to the DEA. DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act,” a spokesperson for the agency said in a statement. “As part of this process, HHS conducted a scientific and medical evaluation for consideration by DEA. Don't believe me, just investigate some of his other roles.The DEA confirmed to POLITICO that it received the letter. (Yeah, I’m definitely biased, but that doesn't mean I'm not also right. Not just because he’s always going to be my favorite Doctor – though that helps – but just because he’s a fantastic actor who deserves all sorts of great parts. It’s nice to see Eccleston making good use of his Leftovers hiatus – and getting involved with more projects generally.


įilming is officially underway as of this week for a likely broadcast at some point in 2015. White Collar’s Marsha Thompson and Eccleston’s Leftovers castmate Paterson Joseph are also part of the cast, along with Jason Merrells, Nicola Stephenson and Peter Fernando. As a consequence of running the safe house, Robert re-questions this incident and uncovers a web of lies. Unexpectedly, he was shot, and she was killed.

Eccleston, who has most recently been seen on HBO drama The Leftovers, will be playing Robert, a retired detective thrust back into the criminal world when he and his wife Katy are asked to turn their remote bed and breakfast into a safe house for protected witnesses and crime victims.Īnd just in case you didn’t think that premise was going to provide enough angst on its own, the consequences of this decision means Robert must face the ongoing effects from a tragic event during his time on the police force, when he was where he was protecting a star witness who was about to testify against her gangland husband.
#SAFE HOUSE 2 SERIES#
The new four-part series is described as a tense thriller set in the beautiful wildnerness of the Lake District, and its story is inspired by the life of a real couple. Christopher Eccleston in his last cop drama, "The Shadow Line" (Photo: BBC) Doctor Who star Christopher Eccleston has been tapped to headline a new crime drama for ITV called Safe House.
